You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment
|
---|---|
Published in |
Genome Medicine, October 2011
|
DOI | 10.1186/gm280 |
Pubmed ID | |
Authors |
Wendy Lorizio, Hope Rugo, Mary S Beattie, Simone Tchu, Teri Melese, Michelle Melisko, Alan HB Wu, H Jeffrey Lawrence, Michele Nikoloff, Elad Ziv |
Abstract |
Pharmacogenetic testing holds major promise in allowing physicians to tailor therapy to patients based on genotype. However, there is little data on the impact of pharmacogenetic test results on patient and clinician choice of therapy. CYP2D6 testing among tamoxifen users offers a potential test case of the use of pharmacogenetic testing in the clinic. We evaluated the effect of CYP2D6 testing in clinical practice to determine whether genotype results affected choice of hormone therapy in a prospective cohort study. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 20% |
United States | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 211 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 1% |
France | 1 | <1% |
Italy | 1 | <1% |
Portugal | 1 | <1% |
Belgium | 1 | <1% |
Brazil | 1 | <1% |
Thailand | 1 | <1% |
Croatia | 1 | <1% |
Unknown | 201 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 38 | 18% |
Student > Ph. D. Student | 34 | 16% |
Student > Master | 31 | 15% |
Student > Bachelor | 26 | 12% |
Other | 11 | 5% |
Other | 27 | 13% |
Unknown | 44 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 55 | 26% |
Agricultural and Biological Sciences | 39 | 18% |
Medicine and Dentistry | 33 | 16% |
Immunology and Microbiology | 7 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
Other | 25 | 12% |
Unknown | 45 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 March 2014.
All research outputs
#2,073,740
of 25,374,917 outputs
Outputs from Genome Medicine
#461
of 1,585 outputs
Outputs of similar age
#10,112
of 144,573 outputs
Outputs of similar age from Genome Medicine
#2
of 16 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,585 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.8. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,573 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.